Fall 2007 Speaker Series: Innovation in Health Care
Wednesdays from 4 - 5 p.m.
McNeil Science and Technology Center, Room 237
September 5
Robert I. Field Read More
Chair, Dept. of Health Policy & Public Health
Professor of Health Policy
"American Health Care Regulation as an Assortment of Public-Private Partnerships"
September 12
Harold Glass, PhD
Research Professor of Health Policy, USP
"The Role of Innovation in a Physician's Decision to Take Part in Clinical Trials"
September 19
Lawrence Poli, PhD
President, Center for Performance Excellence
"The Challenges of Medical Innovation"
September 26
Ira Spector, MD
Vice President, Research & Development, Wyeth Pharmaceuticals
"Metrics and New Drug Development"
Special Day and Time
Monday, October 1
3 p.m. - 4:20 p.m. in Wilson 205
Naoki Ikegami, MD, MA
Professor of Health Policy and Man.
Keio University, Tokyo Japan
"Overview of the Japanese Health Care System"
October 3
Bruce Lamont
CEO, Graphwise LLC
"Innovation in Medicine: Bringing a New Concept to Fruition"
October 10
James Laughlin
Vice President, TTC
"Direct-to-Consumer Advertising and New Drug Adoption"
October 17
M. DeFelice
Vice President, Merck/J&J Joint Venture
"Over-the-Counter Drugs: New Approaches to Innovation"
October 24
John Clark, MD
Vice President, Risk Metrics
"Drug Safety and Medical Innovation"
To read more about our Spring 2007 Speaker Series: Issues in Drug Safety
please click "Read More".
Jan. 24: Robert I. Field, J.D., M.P.H., Ph.D. Read More
Associate Professor of Health Policy
“Post-market drug safety regulation”
Research Professor of Health Policy
“Pharmaceutical clinical trials”
Feb. 7:Richard G. Stefanacci, D.O., M.G.H. Read More
Associate Professor of Health Policy
“Geriatric drug safety concerns”
Feb. 21:David Snyder, Ph.D.
ECRI
“Drug evaluations and review process”
Adjunct Associate Professor, USP
Assistant Director, R&D Management Operations
Centocor R&D Inc.
“Safety assessment in clinical trials”
March 21: Symposium – The Future of Drug Safety Read More
4:30 p.m. – 6:30 p.m., STC 145
March 28:Mark Vermette
President, CrossPhase Consulting
“Drug safety databases and the FDA”
Omnicare
“Long-term care pharmacy drug surveillance”
Vice President, UBC
“Post marketing safety surveillance”
To read more about our Fall 2006 series, please click Read More.
September 6: Richard G. Stefanacci, D.O., M.G.H., M.B.A. Read More
Founding Executive Director, USP Health Policy Institute; Associate Professor of Health Policy
"Geriatric Policy and Medicine"
September 13: Harold Glass, Ph.D. Read More
Professor of Health Policy
"Pharmaceutical Clinical Trials"
September 20: Robert I. Field, J.D., M.P.H., Ph.D.
Director, Health Policy Program; Associate Professor of Health Policy
"Post-Market Drug Safety Surveillance"
September 27: David Nash, M.D., M.B.A. Read More
See his presentation here
Chair, Department of Health Policy at Thomas Jefferson University
"Quality Measurement"
October 4: Albert Wertheimer, Ph.D. Read More
Professor, Temple University
"Pharmaceutical Policy and Outcomes Research"
October 11: Lynn Oppenheim, Ph.D. Read More
President and CEO, Center for Applied Research
Barton Parrott, M.B.A.
Senior Manager, Center for Applied Research
"The Future of Health Care"
October 18: Stephen Metraux, Ph.D. Read More
Assistant Professor of Health Policy
"Mental Health and Community Reentry from Prison"
October 25: Karen Schoelles, M.D., SM Read More
Medical Director, Evidence-Based Practice Center, ECRI
"Health Care Technology Assessment"
November 1: Vivian Valdmanis Read More
Associate Professor of Health Policy
"Health Care in Developing Countries"
November 15: Student Presentation Read More
"Health Disparities"
To read more about our Spring 2006 Series Long Term Health Care: The Problems
click on the "Read More" links below.
February 1: Wayne Pendleton Read More
CEO, LIFE/Penn School of Nursing
Home & Community-Based Long Term Care Options
February 8: Larry Lane Read More
VP, Government Relations; Genesis Healthcare
Current and Future Issues Faced by the Nursing Home Industry
February 15: Neil I. Goldfarb Read More
Director of Research,Dept. of Medical Policy, Jefferson Medical College
Measuring Quality in Long Term Care
March 15: Jim Pezzuti Read More
Director, Division of LTC Clint Services, Dept. of Public Welfare Office of Medical Assistance
Direction and Trends in LTC from Payers Perspective
March 22: J.P. Geronimi Read More
Sr. Manager, Senior Care Marketing, Sanofi-Aventis
The Pharmaceutical Industry's View of Long Term Care
To Read More About our Past Series in the Medicare Drug Benefit
Click on the "Read More" links below:
September 14: Paul Baldwin READ MORE
Executive Director, Long Term Care Pharmacy Alliance
The Impact of Medicare Part D on Long Term Care
September 21: Daniel C. Lyons, MD READ MORE
Senior Vice President, Government Programs, Independence Blue Cross
How a Large Health Plan is Adapting to Medicare Part D
October 12: Mark H. Beers, MD READ MORE
Editor in Chief, The Merck Manuals; Executive Director, Geriatrics and Clinical Literature Merck & Co., Inc.
How will the Beers Criteria Work under Medicare Part D?
|
